NICE Talks

In this episode we’re going to be talking about NICE's evidence standards framework for digital health technologies.

Working alongside system partners, we've produced the framework for the developers and adopters of digital health technologies. It provides them with the information to ensure new technologies are clinically effective and offer economic value.

We’ll be talking to Mark Salmon, a programme director in the Science, Evidence and Analytics directorate at NICE. And by Andrew Davies, the Digital Health Lead at the Association of British HealthTech Industries.

In this episode, we speak with Helen Knight, programme director in NICE’s Centre for Health Technology Evaluation, and Dr Jane Adam, chair of one of our independent appraisal committees. They discuss what our changes mean for patients, the NHS and industry.

In this episode of our NICE Talks podcast, we speak with Professor Gillian Leng, our chief executive, and Dr Mark Kroese, chair of our diagnostics advisory committee. They reflect on the past year and look forward to 2022.

In this month's podcast, we discuss how we worked with stakeholders at the start of the pandemic to produce evidence-based rapid guidelines for COVID-19. We chat with Fiona Glen, NICE's programme director in centre for guidelines and David Chandler, chief executive of the Psoriasis and Psoriatic Arthritis Alliance (PAPAA). They talk about ensuring the guidelines were informed by the best quality evidence and real-world data but also not adversely influenced by during the infodemic.

In this month's podcast, we discuss our health technology evaluation methods, processes and topic selection consultation. We chat with NICE's deputy chief executive and director of the Centre for Health Technology Evaluation, Meindert Boysen, and Victoria Barrett from The Association of the British Pharmaceutical Industry. They talk about what the proposals mean for patients, the NHS and industry, and whether they go far enough.

In our monthly podcast we discuss with Prof Gillian Leng, NICE chief executive, and Marie Burnham, guideline committee chair, why shared decision making is such a vital part of healthcare and the work that went into developing such an important guideline.

NICE’s recent recommendations in its guideline on the assessment and management of chronic pain have generated a lot of debate.

In this episode, we talk with two member of the committee who developed the guideline recommendations.

They are Cathy Stannard, a pain consultant in Gloucestershire and who was the clinical lead on the NICE chronic pain guideline committee. And Colin Wilkinson, who was a lay member on the guideline committee.

This month we discuss why everyone with an interest in what NICE does should take part in the process review consultation.

We're joined by Jennifer Prescott, programme director in the centre for health technology evaluation at NICE and Eric Low, of Eric Low Consulting and the former chief executive of Myeloma UK.

You can take part in the consultation at: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/reviewing-our-process-for-health-technology-evaluation--consultation

Each NICE committee contains at least two patient or patient group representatives. In this episode we find out how NICE's Public Involvement Programme works with these lay members to support their work with NICE and discover what it's like to be a patient representative on a committee. Joining host Matthew Brown are Laura Norburn, senior operations manager for NICE's Public Involvement Programme and Jo Jerrome, chief executive of Thrombosis UK.

How are NICE and the government working to ensure digital health technologies reach NHS patients?

We speak with Lord James Bethell of Romford, the Department of Health and Social Care's minister for innovation and Meindert Boysen, NICE deputy chief executive and director of the centre for health technology evaluation.